Estrogen 101

Estrogen in Perimenopause: What It Does, Why Symptoms Happen, and the FDA Black Box Warning Update (2025–2026) Jamie Gallagher, a nationally board-certified family nurse practitioner and Menopause Society certified practitioner, explains estrogen as a whole-body hormone—not just a reproductive one—affecting the brain (temperature regulation, mood, memory, hot flashes, sleep and brain fog), bones (rapid bone loss around the final period and osteoporosis risk), vaginal/urinary tissues (dryness, discomfort with sex, UTIs and worsening symptoms post-menopause), skin and joints (collagen loss, aches, inflammation), and heart/metabolism (vessel flexibility, cholesterol, insulin response, rising heart disease risk). She outlines common symptom patterns from early perimenopause through post-menopause and emphasizes personalized care. She also reviews the Women’s Health Initiative-driven FDA black box warning placed in 2003 and describes FDA/HHS actions beginning Nov 10, 2025, and label changes approved Feb 12, 2026, removing broad warnings about heart disease, breast cancer, and dementia from several hormone therapy products while noting uterine cancer risk with estrogen-only therapy in women with a uterus. 00:00 Welcome to the Podcast 00:47 Why Estrogen Matters 01:48 Estrogen Receptors Everywhere 02:56 Types of Estrogen Explained 03:56 Brain and Hot Flashes 05:08 Bone Loss and Osteoporosis 06:32 Vaginal and Urinary Changes 07:17 Skin Joints Heart Metabolism 08:33 Symptom Timeline in Midlife 10:10 Black Box Warning History 11:22 FDA Label Changes 2025-2026 12:33 Risks Personalized Decisions 13:39 Wrap Up and Next Episode